More profitable than peers
ROE of 81.6% is well above the personal care median of 19.9%.
Importance 63 / 95 · profitability
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
ROE of 81.6% is well above the personal care median of 19.9%.
Importance 63 / 95 · profitability
Free cash flow has been positive in 6 of the last 6 years.
Importance 44 / 95 · cash quality
EBITDA margin fell from 34.7% to 32.5% of revenue.
Importance 40 / 95 · profitability
Classified by the exchange under Fast Moving Consumer Goods › Fast Moving Consumer Goods › Personal Products › Personal Care.
Peer set used on this page: 3 personal care.
Revenue has compounded at 4.4% a year over 7 years (₹4,462 → ₹6,035) — steady rather than rapid.
Rule REVENUE_COMPOUNDED_MODERATE
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q1 FY27 revenue was ₹1,603 cr, up 11.8% from ₹1,434 cr in Q1 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q2 FY25 | 1,619 | — | 395 | — | 24.4% |
| Q3 FY25 | 1,462 | +4.7% | 323 | −2.2% | 22.1% |
| Q4 FY25 | 1,463 | −1.8% | 355 | −6.5% | 24.3% |
| Q1 FY26 | 1,434 | −4.2% | 321 | −11.9% | 22.4% |
| Q2 FY26 | 1,520 | −6.2% | 328 | −17.1% | 21.6% |
| Q3 FY26 | 1,486 | +1.7% | 324 | +0.3% | 21.8% |
| Q4 FY26 | 1,595 | +9.1% | 353 | −0.5% | 22.1% |
| Q1 FY27 | 1,603 | +11.8% | 343 | +7.0% | 21.4% |
Trailing twelve months to 30 Jun 2026 · sum of the last 4 contiguous quarters
ROE of 81.6% is well above the personal care median of 19.9%.
Rule ROE_ABOVE_PEER_MEDIAN
EBITDA margin fell from 34.7% to 32.5% of revenue.
EBITDA margin has ranged from 27.6% to 34.8% over 7 years and sits at 32.5% now.
Free cash flow has been positive in 6 of the last 6 years.
Rule FCF_CONSISTENTLY_POSITIVE
Ranked against 3 personal care (FY2026, consolidated). No peer-relative rule fired for this company.
COLPAL · 3rd of 3 · set median 5.0%
COLPAL · 1st of 3 · set median 23.1%
COLPAL · 1st of 3 · set median 16.2%
COLPAL · 2nd of 3 · set median 35.0×
On the trailing twelve months. Last full year: P/E 35.6× · P/S 7.7× · ROE 81.6%.
Long-term price performance is shown above.
Price-action indicators as of 2026-10-01. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,040 | 6,035 |
| Total income | 4,500 | 4,574 | 4,872 | 5,126 | 5,280 | 5,757 | 6,179 | 6,124 |
| EBITDA | 1,274 | 1,251 | 1,540 | 1,592 | 1,601 | 1,977 | 2,097 | 1,959 |
| Profit before tax | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,930 | 1,784 |
| Net profit | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,437 | 1,325 |
| EPS (₹) | 28.5 | 30.0 | 38.1 | 39.6 | 38.5 | 48.7 | 52.8 | 48.7 |
| Net worth | 1,447 | 1,594 | 1,166 | 1,735 | 1,716 | 1,874 | 1,664 | 1,584 |
| Total debt | 78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | — | — | 784 | 1,626 | 1,176 | 1,199 | 1,394 | 1,806 |
| Free cash flow | — | — | 726 | 1,576 | 1,107 | 1,123 | 1,323 | 1,730 |
| Ratio | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||
| Revenue growth YoY | — | 1.4 | 7.0 | 5.3 | 2.5 | 8.7 | 6.3 | -0.1 |
| Profit growth YoY | — | 5.3 | 26.8 | 4.1 | -2.9 | 26.4 | 8.5 | -7.8 |
| Profitability | ||||||||
| EBITDA margin % | 28.5 | 27.6 | 31.8 | 31.2 | 30.6 | 34.8 | 34.7 | 32.5 |
| Net margin % | 17.2 | 17.8 | 21.3 | 21.0 | 19.8 | 23.0 | 23.3 | 21.6 |
| Return on equity % | 53.6 | 53.7 | 75.0 | 74.4 | 60.7 | 73.7 | 81.2 | 81.6 |
| Return on capital % | 73.1 | 67.5 | 98.4 | 97.6 | 82.6 | 100.6 | 109.3 | 111.6 |
| Leverage & cash | ||||||||
| Debt to equity | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash flow ÷ profit | — | — | 0.76 | 1.51 | 1.12 | 0.91 | 0.97 | 1.36 |
| Current ratio | 0.96 | 1.16 | 0.85 | 1.37 | 1.43 | 1.78 | 1.65 | 1.28 |